← FDA Drug Approvals (Drugs@FDA)

NYSTATIN AND TRIAMCINOLONE ACETONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2017-08-14

Drug application

FDA Application #
ANDA208479
Application type
Abbreviated New Drug Application (Generic)
Brand name
NYSTATIN AND TRIAMCINOLONE ACETONIDE
Generic name
NYSTATIN, TRIAMCINOLONE ACETONIDE
Active ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDE
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
PADAGIS ISRAEL
Manufacturer
Padagis Israel Pharmaceuticals Ltd
First approval
2017-08-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown